Ikejiri Masahiro, Bernardo M Margarida, Meroueh Samy O, Brown Stephen, Chang Mayland, Fridman Rafael, Mobashery Shahriar
Department of Chemistry and Biochemistry and the Walther Cancer Research Center, University of Notre Dame, Notre Dame, Indiana 45665, USA.
J Org Chem. 2005 Jul 8;70(14):5709-12. doi: 10.1021/jo050339+.
[structure: see text] Matrix metalloproteinases (MMPs), of which 26 are known, have been implicated in a number of pathological conditions, including tumor metastasis. We have previously described the first mechanism-based inhibitor for MMPs (J. Am. Chem. Soc. 2000, 122, 6799-6800), which in chemistry mediated by the active site zinc ion selectively and covalently inhibits MMP-2, -3, and -9. Computational analyses indicated that this selectivity in inhibition of MMPs could be improved by design of new variants of the inhibitor class. We report herein the syntheses of methyl 2-(4-{4-[(2-thiiranylpropyl)sulfonyl]phenoxy}phenyl)acetate (3) and 2-(4-{4-[(2-thiiranylpropyl)sulfonyl]phenoxy}phenyl)acetic acid (4), and show that compound 3 serves as a mechanism-based inhibitor exclusively for MMP-2. This molecule should prove useful in delineating the functions of MMP-2 in biological systems.
[结构:见正文] 基质金属蛋白酶(MMPs)共有26种,已被证实与多种病理状况有关,包括肿瘤转移。我们之前报道了首个基于作用机制的MMPs抑制剂(《美国化学会志》,2000年,第122卷,6799 - 6800页),该抑制剂在由活性位点锌离子介导的化学反应中,能选择性地共价抑制MMP - 2、- 3和- 9。计算分析表明,通过设计该抑制剂类别的新变体,可以提高对MMPs抑制的选择性。我们在此报告2-(4-{4-[(2-硫杂环丙基丙基)磺酰基]苯氧基}苯基)乙酸甲酯(3)和2-(4-{4-[(2-硫杂环丙基丙基)磺酰基]苯氧基}苯基)乙酸(4)的合成,并表明化合物3仅作为基于作用机制的MMP - 2抑制剂。该分子应有助于阐明MMP - 2在生物系统中的功能。